Switch theme
Sign up to access all valuation multiples
Telemedycyna Polska SA offers telecardiology services for individual patients and medical facilities in Poland. The company offers cardiologic care services through telephone and Internet. The company also provides telemedical services to health centres.
2005
35
Last FY Revenue $1.4M
Last FY EBITDA -$0.5M
$2.4M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Telemedycyna Polska achieved revenue of $1.4M and an EBITDA of -$0.5M.
Telemedycyna Polska expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Telemedycyna Polska valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $1.4M | XXX | XXX | XXX |
| Gross Profit | XXX | $1.3M | XXX | XXX | XXX |
| Gross Margin | XXX | 89% | XXX | XXX | XXX |
| EBITDA | XXX | -$0.5M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -38% | XXX | XXX | XXX |
| EBIT | XXX | -$0.6M | XXX | XXX | XXX |
| EBIT Margin | XXX | -42% | XXX | XXX | XXX |
| Net Profit | XXX | -$0.6M | XXX | XXX | XXX |
| Net Margin | XXX | -44% | XXX | XXX | XXX |
| Net Debt | XXX | $30K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Telemedycyna Polska's stock price is PLN 1 (or $0).
Telemedycyna Polska has current market cap of PLN 8.8M (or $2.3M), and EV of PLN 9.2M (or $2.4M).
See Telemedycyna Polska trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.4M | $2.3M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Telemedycyna Polska has market cap of $2.3M and EV of $2.4M.
Telemedycyna Polska's trades at 1.7x EV/Revenue multiple, and -4.5x EV/EBITDA.
Equity research analysts estimate Telemedycyna Polska's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Telemedycyna Polska's P/E ratio is not available.
See valuation multiples for Telemedycyna Polska and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.3M | XXX | $2.3M | XXX | XXX | XXX |
| EV (current) | $2.4M | XXX | $2.4M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -4.5x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -4.0x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -3.6x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -5.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialTelemedycyna Polska's revenue per employee in the last FY averaged $41K, while opex per employee averaged $0.1M for the same period.
Telemedycyna Polska's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Telemedycyna Polska's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Telemedycyna Polska and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -38% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $41K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 131% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Telemedycyna Polska acquired XXX companies to date.
Last acquisition by Telemedycyna Polska was XXXXXXXX, XXXXX XXXXX XXXXXX . Telemedycyna Polska acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Telemedycyna Polska founded? | Telemedycyna Polska was founded in 2005. |
| Where is Telemedycyna Polska headquartered? | Telemedycyna Polska is headquartered in Poland. |
| How many employees does Telemedycyna Polska have? | As of today, Telemedycyna Polska has 35 employees. |
| Is Telemedycyna Polska publicy listed? | Yes, Telemedycyna Polska is a public company listed on WAR. |
| What is the stock symbol of Telemedycyna Polska? | Telemedycyna Polska trades under TMP ticker. |
| When did Telemedycyna Polska go public? | Telemedycyna Polska went public in 2010. |
| Who are competitors of Telemedycyna Polska? | Similar companies to Telemedycyna Polska include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
| What is the current market cap of Telemedycyna Polska? | Telemedycyna Polska's current market cap is $2.3M |
| Is Telemedycyna Polska profitable? | Yes, Telemedycyna Polska is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
